Ascentage Pharma Group International logo

Ascentage Pharma Group International Share Price Today

(NASDAQ: AAPG)

Ascentage Pharma Group International share price is $18.9 & ₹1,652.69 as on 11 Feb 2025, 2.30 'hrs' IST

$18.9

0.23

(1.23%)

Market is closed - opens 8 PM, 11 Feb 2025

View live Ascentage Pharma Group International share price in Dollar and Rupees. Guide to invest in Ascentage Pharma Group International stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Ascentage Pharma Group International, along with analyst recommendations, forecasts, and comprehensive financials.

Ascentage Pharma Group International share price movements

  • Today's Low: $18.51
    Today's High: $18.99

    Day's Volatility :2.52%

  • 52 Weeks Low: $17.00
    52 Weeks High: $19.37

    52 Weeks Volatility :12.24%

Ascentage Pharma Group International (AAPG) Returns

PeriodAscentage Pharma Group InternationalIndex (Russel 2000)
3 Months
8.23%
0.0%
6 Months
8.23%
0.0%
1 Year
8.23%
0.0%
3 Years
8.23%
-13.8%

Ascentage Pharma Group International (AAPG) Key Statistics

in dollars & INR

Previous Close
$18.67
Open
$18.7
Today's High
$18.99
Today's Low
$18.5116
Today's Volume
$320.2K
52 Week High
$19.37
52 Week Low
$17.0
Revenue TTM
$0.0
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

How to invest in Ascentage Pharma Group International Stock (AAPG) from India?

It is very easy for Indian residents to invest directly in Ascentage Pharma Group International from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ascentage Pharma Group International stock in both Indian Rupees (INR) and US Dollars (USD). Search for Ascentage Pharma Group International or AAPG on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ascentage Pharma Group International or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ascentage Pharma Group International shares which would translate to 0.046 fractional shares of Ascentage Pharma Group International as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Ascentage Pharma Group International, in just a few clicks!

Returns in Ascentage Pharma Group International (AAPG) for Indian investors in Rupees

The Ascentage Pharma Group International stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ascentage Pharma Group International investment value today

Current value as on today

₹1,14,919

Returns

₹14,919

(+14.92%)

Returns from Ascentage Pharma Group International Stock

₹9,565 (+9.57%)

Dollar Returns

₹5,354 (+5.35%)

Indian investors sentiment towards Ascentage Pharma Group International (AAPG)

0%

Period: Jan 11, 2025 to Feb 10, 2025. Change in 30 Days versus previous period

Search interest for Ascentage Pharma Group International Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Ascentage Pharma Group International

Insights on Ascentage Pharma Group International Stock (Ticker Symbol: AAPG)

  • Price Movement

    In the last 7 days, AAPG stock has moved up by 2.6%

Ascentage Pharma Group International (AAPG) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Ascentage Pharma Group International logo
8.23%
8.23%
8.23%
8.23%
8.23%
Biontech Se logo
3.4%
41.97%
25.3%
-23.89%
283.84%
Regeneron Pharmaceuticals, Inc. logo
-0.96%
-38.7%
-25.03%
13.87%
78.03%
Vertex Pharmaceuticals Incorporated logo
13.54%
0.37%
12.14%
102.97%
95.48%
Alnylam Pharmaceuticals, Inc. logo
6.94%
3.2%
63.1%
85.79%
112.29%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Ascentage Pharma Group International logo
NA
NA
NA
0.0
0.0
0.0
NA
NA
Biontech Se logo
160.8
NA
0.04
-3.29
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
18.83
18.83
1.15
43.84
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.28
0.48
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Ascentage Pharma Group International logo
NA
NA
8.23%
NA
0.0%
Biontech Se logo
Buy
$28.8B
283.84%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$78.9B
78.03%
18.83
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$123.9B
95.48%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$35.9B
112.29%
NA
-15.86%

About Ascentage Pharma Group International

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; APG-115, an oral small molecule inhibitor of the MDM2-p53 protein-protein interactions to treat solid tumors and hematological malignancies; and APG-1252, a small molecule drug to restore apoptosis through dual inhibition of the Bcl-2 and Bcl-xL proteins for the treatment of small-cell lung cancer, non-small cell lung cancer, neuroendocrine tumor, and non-Hodgkin's lymphoma. In addition, the company is developing APG-1387, a small molecule inhibitor of apoptosis proteins for advanced solid tumors and chronic HBV infection; APG-2449, an oral inhibitor of FAK, ROS1, and ALK kinases; APG-5918, an orally available and selective embryonic ectoderm development inhibitor; APG-265, a MDM2 protein degrader; and UBX1967/1325, which are Bcl-2 inhibitors. In addition, it is also involved in medical research and development; clinical development; clinical trial operation; venture capital investment; rental services; and science and technology promotion services. The company has collaboration relationships with biotechnology and pharmaceutical companies; and research institutions. Ascentage Pharma Group International was founded in 2009 and is headquartered in Suzhou, China.
Organization
Ascentage Pharma Group International
Employees
574
CEO
Dr. Dajun Yang M.D., Ph.D.
Industry
Miscellaneous

Management People of Ascentage Pharma Group International

NameTitle
Dr. Dajun Yang M.D., Ph.D.
Co-Founder, Chairman & CEO
Dr. Shaomeng Wang Ph.D.
Co-Founder, Chief Scientific Advisor & Non-Executive Director
Dr. Ming Guo
Co-Founder
Mr. Jin Cao
Head of Finance
Mr. Thomas Joseph Knapp J.D.
Senior VP & General Counsel
Dr. Yifan Zhai M.D., Ph.D.
Chief Medical Officer
Mr. Raymond Jeffrey Kmetz
Chief Business Officer
Dr. Chongdong Fu
Senior VP & Head of CMC
Mr. Cheung Ki Wong A.C.I.S., A.C.S., FCPA
Company Secretary

Important FAQs about investing in AAPG Stock from India :

What is Ascentage Pharma Group International share price today?

Ascentage Pharma Group International share price today stands at $18.90, Open: $18.70 ; Previous Close: $18.67 ; High: $18.99 ; Low: $18.51 ; 52 Week High: $19.37 ; 52 Week Low: $17.00.

The stock opens at $18.70, after a previous close of $18.67. The stock reached a daily high of $18.99 and a low of $18.51, with a 52-week high of $19.37 and a 52-week low of $17.00.

Can Indians buy Ascentage Pharma Group International shares?

Yes, Indians can invest in the Ascentage Pharma Group International (AAPG) from India.

With INDmoney, you can buy Ascentage Pharma Group International at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Ascentage Pharma Group International at zero transaction cost.

How can I buy Ascentage Pharma Group International shares from India?

It is very easy to buy Ascentage Pharma Group International from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ascentage Pharma Group International (AAPG) be purchased?

Yes, you can buy fractional shares of Ascentage Pharma Group International with INDmoney app.

What are the documents required to start investing in Ascentage Pharma Group International stocks?

To start investing in Ascentage Pharma Group International, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Ascentage Pharma Group International Stock (AAPG)?

Today’s highest price of Ascentage Pharma Group International (AAPG) is $18.99.

Today’s lowest price of Ascentage Pharma Group International (AAPG) is $18.51.

What is today's market capitalisation of Ascentage Pharma Group International?

Today's market capitalisation of Ascentage Pharma Group International AAPG is

What is the 52 Week High and Low Range of Ascentage Pharma Group International Stock (AAPG)?

  • 52 Week High

    $19.37

  • 52 Week Low

    $17.00

What are the historical returns of Ascentage Pharma Group International (AAPG)?

  • 1 Month Returns

    8.23%

  • 3 Months Returns

    8.23%

  • 1 Year Returns

    8.23%

  • 5 Years Returns

    8.23%

Who is the Chief Executive Officer (CEO) of Ascentage Pharma Group International ?

Dr. Dajun Yang M.D., Ph.D. is the current Chief Executive Officer (CEO) of Ascentage Pharma Group International.